Pediatric ALL Clinical Trial
Official title:
Umbilical Vessel Catheterization Under ECG Monitoring and Guidance
NCT number | NCT03898596 |
Other study ID # | 49778 |
Secondary ID | |
Status | Recruiting |
Phase | N/A |
First received | |
Last updated | |
Start date | August 25, 2020 |
Est. completion date | June 2024 |
Umbilical venous catheters (UVC) are typically places with poor guidance and some radiological confirmation. Misplacement of the catheter could lead to its placement in other unintended anatomical areas such as the liver or the spleen, which could be detrimental in critically-ill infants. Our study aims at using a more non-invasive means of placing and continuously monitoring catheter placement using superficial electrocardiogram (ECG) tracings.
Status | Recruiting |
Enrollment | 150 |
Est. completion date | June 2024 |
Est. primary completion date | June 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Day to 45 Days |
Eligibility | Inclusion Criteria: - Neonate pediatric patient - 2 - 6kg - Require or currently have UVC Exclusion Criteria: - Participants who do not consent or have parental consent - Patients who are clinically unstable |
Country | Name | City | State |
---|---|---|---|
United States | Lucille Packard Children's Hospital | Palo Alto | California |
Lead Sponsor | Collaborator |
---|---|
Stanford University |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Electrocardiogram Readings | A normal heart rhythm contains a P wave, a QRS, and a T wave. Readings will include amplitude, deflection, and duration of such elements to record electrical heart activity. | Duration of ECG placement and reading (typically 15 minutes) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT05818644 -
Hepatic Artery Stenosis and Thrombosis After Liver Transplantation in Children
|
||
Not yet recruiting |
NCT06018324 -
CloudCare in the Treatment of Type 1 Diabetes in Pediatrics
|
||
Not yet recruiting |
NCT04523623 -
Pain Control Differences Between Oxycodone and Ibuprofen in Children With Isolated Forearm Injuries
|
N/A | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT03385681 -
Pediatric Pain Management - an Intervention Study
|
N/A | |
Completed |
NCT00229671 -
Medication Errors and Adverse Drug Events (ADEs) in Ambulatory Pediatrics
|
N/A | |
Completed |
NCT04465370 -
Pediatric Cardiac Output Monitoring Observational Study
|
||
Recruiting |
NCT04100070 -
Intensive Versus Standard One Year Monitoring on Glycaemic Control After Initiating CSII in Children With DT1. DEEP Study
|
N/A | |
Not yet recruiting |
NCT06035757 -
The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery
|
Phase 4 | |
Completed |
NCT03369847 -
Inhaled Steroids for Pediatric Asthma at Pediatric Emergency Medicine Discharge
|
Phase 4 | |
Completed |
NCT05474170 -
Impact of 2 Resuscitation Sequences on Management of Simulated Pediatric Cardiac Arrest
|
N/A | |
Recruiting |
NCT05230004 -
Innovative Prosthetic Systems for Pediatric Limb Loss to Accommodate Growth
|
N/A | |
Completed |
NCT05818215 -
Impact of the Qatar 2022 FIFA World Cup on PED Use and Misuse Patterns
|
||
Completed |
NCT06376188 -
Improving Breaking Bad News in Pediatrics by Simulated Communication
|
N/A | |
Completed |
NCT05731401 -
Expressed Beliefs About the Cause of Pain in a Paediatric Population
|
||
Completed |
NCT04589910 -
Measuring Thickness of the Normal Diaphragm in Children Via Ultrasound.
|
N/A | |
Recruiting |
NCT04252508 -
Impact of a Double-reading Animated Film (Child, Parents) in Preoperative on the Anxiety of Children Upon Arrival at the Operating Room
|
N/A | |
Completed |
NCT04655378 -
Validation of the IgA1 Detection Method With Gradient Glycosylation by Mass Spectrometry as a Potential Marker of Renal Involvement in Pediatric Rheumatoid Purpura
|
||
Completed |
NCT04610918 -
Comparing Body Composition Assessment Methods
|
||
Completed |
NCT03964259 -
Reduced IV Fluids to Improve Clearance of HDMTX in Children w/Lymphoma or Acute Lymphoblastic Leukemia
|
Phase 1 |